Market Cap (In USD)
393.52 Million
Revenue (In USD)
5.71 Million
Net Income (In USD)
-110.56 Million
Avg. Volume
4.78 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.45-6.72
- PE
- -3.29
- EPS
- -0.94
- Beta Value
- 2.187
- ISIN
- US00091E1091
- CUSIP
- 00091E109
- CIK
- 1672688
- Shares
- 127353000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Sean McClain
- Employee Count
- -
- Website
- https://www.absci.com
- Ipo Date
- 2021-07-22
- Details
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
More Stocks
-
603238
-
PRLH
-
600513
-
SITAENTSita Enterprises Limited
SITAENT
-
SYUPAnbc, Inc.
SYUP
-
IQAIFIQ-AI Limited
IQAIF
-
603258
-
600571Sunyard Technology Co.,Ltd
600571